학술논문

FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 15 September 2023, 29(18):3573-3578)
Subject
Language
English
ISSN
15573265
10780432